Management of
Surgical Wounds
Management of Surgical Wounds
Microlyte® Surgical provides you with a
new antimicrobial tool for management
of surgical wounds.
Microlyte® Surgical provides you with a new antimicrobial tool for management of surgical wounds.
Created for surgeons—
by surgeons.
The world’s first and only fully-synthetic, antimicrobial, and bioresorbable matrix
Microbial contamination is a threat to healing of all surgical wounds. Microlyte® Surgical contains bacteria-killing antimicrobial silver. Reduction of bacterial bioburden may reduce microbial colonization and risks of wound infection. This addition of ionic and metallic silver provides rapid, effective, and sustained antimicrobial activity.
Microlyte® Surgical absorbs wound fluid and transforms into a bioresorbable material that intimately contours to the underlying surgical wound. It maintains a physiologically moist microenvironment. In vitro and in vivo, studies indicate that components of the matrix allow cell growth and neovascularization. 1,2,3
“The property that I find unique in Microlyte is the total conformation to the wound bed as the thin film melts into all the crevices of a wound likely where the bacteria are hiding and preventing healing. It is also very easy to apply and may decrease irritation, such as itching, caused by other products.”
Angela Gibson, MD, PhD, FACS
Burn Surgeon and Medical Director UW Health
Annual Number of Surgeries
What is your cost of Surgical Site Infections?
There are roughly 5,000 hospital in the US doing a total of 30 million surgical procedures each year. This translates to an average of 6,000 surgeries per hospital per year.6
Across all specialties, surgical site infections (SSI) occur at a 2.6% rate. The typical SSI results in an additional 7-10 day hospital stay and a cost of treat as high as $30,000, which is not reimbursed by Medicare.
SSIs represent a significant cost to your hospital and health system.
- Average SSI Rate: 2.6% (780,000 SSIs/30 million procedures)7
- Number of SSIs: 6,000 at 2.6% = 156
- Average Cost Per SSI: $30,0007,8
Surgical Site Infections can happen anywhere.
The average Surgical Site Infection rate is 2.6%. Hover over the red markers and you’ll notice some common Surgical Site Infection Rates specific to particular specialties.
Microlyte® Surgical reduces microbial burden through a low but effective dose of silver in the surgical matrix for improved management of surgical wounds. Click below to learn more about the Microlyte® technology.
(post-mastectomy reconstruction)
(breast augmentation)
without prophylaxis: 10.4% SSI rate
with prophylaxis: 5.4% SSI rate
“We like using this a lot, especially in wounds that have an irregular surface. It conforms to the wound base very readily. The multi-day antimicrobial effect is nice for wounds that may require compression or a secondary dressing that we don’t want to change everyday.”
Jeffrey A. Niezgoda, MD, FACHM, MAPWCA, CHWS
President and Medical Director AZH Wound and Vascular
Case Studies
Vape Pen Explosion Burn Wound
Michael Schurr, MD, Sarah Waterman-Manning, MD
Mountain Area Health Education Center; Asheville, NC
A burn from a vape pen explosion showed full re-epithelialization 7 days after a single treatment with Microlyte® Matrix.
Prophylactic Treatment of a Surgical Site Infection in an At-Risk Patient
Michael Schurr, MD, Sarah Waterman-Manning, MD
Mountain Area Health Education Center; Asheville, NC
A surgical wound contaminated with MRSA was treated with Microlyte® Surgical and closed successful in 14days.
Treatment for Chronic Contaminated Wound After Total Thyroidectomy
Thea Price, MD
Rush University Medical Center, Chicago, IL
A post-surgical tracheal abscess was removed and the surgical site was successfully closed using Microlyte® Surgical.
REFERENCES 1 A Agarwal, et al. Biomaterials, 31 (4), 680-690, 2010. 2 Systemic Toxicity, Local Tissue Response, and Wound Healing Study of Microlyte Ag wound dressing, Following Repeated Treatment to Full-Thickness Wounds in Rats – 28 Days. Study 15T_41113_02, 2015. Data on file, Imbed Biosciences. 3 MTT cytotoxicity testing conducted at NAMSA. Data on file at Imbed Biosciences. 6 Weigelt, J.A., et al. Am J Infect Control, 38, 112-120, 2010. 7 American Health Quality Association. 56 hospitals collaborate to prevent surgical infection: QIO-led program cuts infection rate 27% in a year, 2005. 8 Anderson, D.J., et al. PLOS One. 4(12), 1-7 2009.